Hemi 2023: Year in Review
January
Smart Radar System was named in the CES 2023 Innovation Award list, honoring outstanding design and engineering in consumer technology. The company was also honored as one of the 2022 Top 19 Technology Performances announced by NAEK (the National Academy of Engineering of Korea).
Point One Navigation launched FusionEngine software that combines data from multiple sensors to assure high accuracy, safety, and integrity for higher levels of autonomous vehicles. The company was also a team sponsor at the CES Indy racing challenge. The program and the technology are important in the development of safer vehicles.
Alcatraz AI published a new e-book, 4 Biometric Access Control Trends You Can’t Ignore in 2023, covering topics such as the importance of frictionless solutions and the emergence of legislation impacting security technologies. It also examines the growth of multi-modal authentication, the adoption of cloud-based IT systems, and the acceleration of edge computing.
Angelo Stracquatanio, CEO and Co-founder of Apprentice.io, was asked to join the Forbes Technology Council. The Council committee invited Angelo to join the elite group of tech leaders based on the depth and diversity of his experience and knowledge as a senior-level technology executive.
MemryX Inc. announced the opening of its engineering center in Bangalore, India. The Bangalore site complements existing MemryX engineering capabilities in Taipei, Hsinchu, and Ann Arbor.
metaMe Health signed a deal to license a new gut-directed hypnotherapy protocol designed to treat functional dyspepsia.
February
Persephone Biosciences collaborated with Kroger Health to recruit for the ARGONAUT clinical study to identify microbiome-based biomarkers indicative of colorectal cancer. The study is being run by Persephone to advance the understanding of gut and immune health and how it can be applied to various disease areas, like CRC.
Mythic Therapeutics announced its collaboration with Nona Biosciences to advance next-gen biotherapeutics innovation.
Alcatraz.AI received certification from the Bureau of Indian Standards (BIS) for its flagship biometric access control device, the Rock. The company also announced the addition of web-based, mobile enrollment, and privacy consent management to its facial authentication product.
MemryX Inc. formed a partnership with Edge Impulse to streamline the development, testing, and deployment of AI models on MemryX's advanced AI accelerator chips.
March
Apprentice.io raised an additional $65M in funding, bringing the company's total funding to $207M. This financing capped off a stellar year for the company, with 3.4x year-over-year Tempo revenue growth, 218% net customer retention, inclusion in Gartner’s Manufacturing Execution System Magic Quadrant, and recognition on the Inc. 5000 and Deloitte Fast 500 as one of the fastest-growing companies in America.
Jakub Dryjas, CEO of Tensorflight, spoke with The Center for Data Innovation to discuss property intelligence, insure-tech data, and Tensorflight’s partnership to help rebuild Ukraine since the onset of the war.
The California Energy Commission recommended that Ample be awarded a grant from the state to scale up its manufacturing capabilities in the Bay Area. The $15 million grant will go towards expanding capacity at its Brisbane, CA module plant to better serve a growing customer base.
April
Mythic Therapeutics announced the first subject had been dosed in the Phase 1 KisMET-01 clinical trial of MYTX-011. MYTX-011 is being investigated for the treatment of patients with locally advanced, recurrent, or metastatic non-small cell lung cancer.
MemryX announced its partnership with Nota.ai. Developers can now use Nota.ai’s software platform to search, compress, and automatically deploy artificial intelligence models on MemryX edge AI processors.
Ivan Liachko, co-founder and CEO of Phase Genomics, was a finalist for Startup CEO of the Year at the GeekWire Awards.
Phase Genomics announced details of a collaboration leveraging its proprietary OncoTerra™ cytogenomics platform and the Element AVITI System for next-generation sequencing (NGS). Phase Genomics’ OncoTerra platform is the first offering to deliver the value of scalable cytogenomics for solid-tumor malignancies in the research setting.
MemryX distinguishes itself in the AI/ML space with its MX3 Edge AI Accelerator chip featuring an innovative "at-memory" architecture. By storing all required weights within its on-chip memories, the MX3 ensures only data input and results output, reducing the burden on the host processor.
May
Studies show that digital gut-directed hypnotherapy resulted in greater improvement in abdominal pain and stool symptoms in patients with IBS, supporting the work of metaMe Health, a pioneer in prescription-based therapeutics utilizing hypnosis.
Ample lets drivers get a fully charged electric car battery in minutes while sparing cities the expense of installing fast charging stations. When low on power, a driver can park their vehicle inside the Ample battery-swapping station. Operated through an app, a platform then lifts the vehicle to facilitate the mechanical swap.
Apprentice.io was named a Visionary in the 2023 Gartner® Magic Quadrant for Manufacturing Execution Systems (MES). The company was recognized as a Visionary for its Completeness of Vision and Ability to Execute.
June
The KOSDAQ Market Division of the Korea Exchange approved the preliminary examination for listing Smart Rader System.
Mythic Therapeutics’ trial in progress on the company’s investigational cMET-targeting Antibody-drug Conjugates (ADC), MYTX-011, for the treatment of patients diagnosed with locally advanced, recurrent, or metastatic Non-small cell lung cancer (NSCLC).
Persephone Biosciences was mentioned in an article by Precision Medicine Online about microbiome-based cancer treatments. Stephanie Culler, CEO, discussed how the company is developing new tools to genetically engineer the microbes in our guts.
Point One Navigation and Septentrio have expanded their precision location solutions, including Point One's Polaris correction network and Septentrio RTK receivers, throughout Western Europe.
July
Ample introduced its modular electric vehicle battery swapping technology to Mitsubishi Fuso's electric trucks, marking its first foray into larger vehicles after previously deploying the tech for ride-hail vehicles in San Francisco and Madrid.
Alcatraz AI unveiled the Rock M, a cutting-edge face biometrics scanner designed for seamless integration into various applications.
August
Smart Radar System debuted on the KOSDAQ, entering the public market. This will enable the company to accelerate its global expansion plans, further research and development initiatives, and continue delivering groundbreaking radar solutions to clients worldwide.
Persephone Biosciences leads groundbreaking research focused on infants to genetically engineer beneficial bacteria to restore crucial microbes in babies. Recent regulatory approvals highlight the potential of microbiome-based therapies in the treatment of recurrent C. difficile infection.
Phase Genomics is on the cutting edge of cancer diagnostics with $2.5 million in grant funding. The funds will go toward developing the Chromosomal Aberration in Oncology Score (ChAOS), a groundbreaking tool for guiding treatment decisions and assessing risks in certain cancers.
Fergus Chan was named a Silicon Valley Business Journal 2023 40 Under 40 honoree. Chan, a serial entrepreneur, co-founded Hemi portfolio Epinomics (now part of 10xGenomics), harnessing the power of analytics to revolutionize cancer treatment within the field of genomics cloud technology.
Apprentice.io made it onto Forbes' list of The Next Billion-Dollar Startups for 2023. The company also unveiled a major release of its Tempo Manufacturing Cloud, emphasizing the enhancement of product capabilities for modern commercial manufacturing.
Mythic Therapeutics takes a groundbreaking approach with their antibody-drug conjugate, MYTX-011, aiming for higher tolerability and a broader range of target expression.
September
Mythic Therapeutics received Fast Track designation from the FDA for its groundbreaking ADC therapy MYTX-011, targeting cMET in non-small cell lung cancer (NSCLC) patients.
Point One Navigation launched its groundbreaking GraphQL API, revolutionizing integration and observability for GNSS-powered devices.
Apprentice.io announced its partnership with Minaris Regenerative Medicine, a top CDMO in cell and gene therapies.
October
Persephone Biosciences and Ginkgo Bioworks successfully concluded their collaborative effort by developing a reusable Bacteroides anaerobic engineering toolkit, a breakthrough in synthetic biology.
November
Hemi's Amy Gu spoke on a panel discussing Strategies for the Next Era of Intelligent Investments at the Mobility Innovators Forum.
Phase Genomics unveiled groundbreaking data from its OncoTerra cytogenomics platform, presented on the cutting-edge AVITI next-gen sequencing system, marking a revolutionary stride in rapid risk stratification for acute myeloid leukemia.
Point One Navigation introduced its Atlas inertial navigation system, a significant advancement in real-time precision location technology.
December
Ample announced a partnership with Stellantis, parent company of Chrysler. The collaboration involves integrating Ample's swappable battery technology into Stellantis' rental EV fleet to alleviate concerns about range and extended charging durations.
